U.S. Code · Título 42
Federally-funded research with enhanced pathogens of pandemic potential
42 U.S.C. § 6627
Office of the Law Revision Counsel · release 119-142
Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.
Review and oversight of enhanced pathogens of pandemic potential
In general
The Director of the Office of Science and Technology Policy (referred to in this section as the “Director”), in consultation with the heads of relevant Federal departments and agencies, shall—
not later than 1 year after December 29, 2022—
Requirements
The policy established pursuant to paragraph (1) shall include—
consistent procedures across relevant Federal department and agencies to ensure that—
Clarification
Reviews required pursuant to this section shall be in addition to any applicable requirements for research project applications required under the Public Health Service Act [42 U.S.C. 201 et seq.], including reviews required under section 492 of such Act (42 U.S.C. 289a), as applicable, or other applicable laws.
Implementation
In general
The Director shall direct all heads of relevant Federal departments and agencies to update, modernize, or promulgate applicable implementing guidance to implement the requirements of this section.
Updates
Consistent with the requirements under subsection (a)(1)(B), the Director shall require all heads of relevant Federal departments and agencies to update such policies consistent with any changes to the policy established pursuant to subsection (a)(1).
Limitations on countries of concern conducting certain research
In general
Beginning not later than 60 days after December 29, 2022, the Secretary of Health and Human Services shall not fund research conducted by a foreign entity at a facility located in a country of concern, in the estimation of the Director of National Intelligence or the head of another relevant Federal department or agency, as appropriate, in consultation with the Secretary of Health and Human Services, involving pathogens of pandemic potential or biological agents or toxins listed pursuant to section 351A(a)(1) of the Public Health Service Act (42 U.S.C. 262a(a)(1)).
Conditions for lifting or suspending prohibition
The Secretary of Health and Human Services may lift or suspend the prohibition of funding under paragraph (1)—
(Pub. L. 117–328, div. FF, title II, § 2315, Dec. 29, 2022, 136 Stat. 5763.)